KR890011598A - 정신병 치료용 이미다조 벤조디아제핀 - Google Patents

정신병 치료용 이미다조 벤조디아제핀 Download PDF

Info

Publication number
KR890011598A
KR890011598A KR1019890000282A KR890000282A KR890011598A KR 890011598 A KR890011598 A KR 890011598A KR 1019890000282 A KR1019890000282 A KR 1019890000282A KR 890000282 A KR890000282 A KR 890000282A KR 890011598 A KR890011598 A KR 890011598A
Authority
KR
South Korea
Prior art keywords
treatment
compound
particular schizophrenia
medicament
haloperidol
Prior art date
Application number
KR1019890000282A
Other languages
English (en)
Other versions
KR970010055B1 (ko
Inventor
메르쯔 발테르
Original Assignee
장-쟉끄 오가이, 프라돌린 클라우스 너
에프. 호프만-라 로슈 앤드 캄파니 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 장-쟉끄 오가이, 프라돌린 클라우스 너, 에프. 호프만-라 로슈 앤드 캄파니 아크티엔게젤샤프트 filed Critical 장-쟉끄 오가이, 프라돌린 클라우스 너
Publication of KR890011598A publication Critical patent/KR890011598A/ko
Application granted granted Critical
Publication of KR970010055B1 publication Critical patent/KR970010055B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Abstract

내용 없음

Description

정신병 치료용 이미다조 벤조디아제핀
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 정신질환, 특히 정신분열증의 치료 및 이의 악화를 방지하기 위한 약제의 제조에 있어서, 하기 구조식의 화합물 A인 ±-부틸(S)-8-브로모-11,12,13,13a-테트라하이드로-9-옥소-9H-이미다졸[1,5-a]피롤로-[2,1-c][1,4]벤조디아제핀-1-카복실레이트의 용도.
  2. 제1항에 있어서, 정신질환, 특히 정신분열증의 치료 및 이의 약화를 방지하기 위한 약제의 제조에 있어서 할로페리돌과 같은 신경이 완제와 혼합한 A의 용도.
  3. 정신질환 특히 정신분열증의 치료 및 이의 악화를 방지하기 위한, 제1항에서 정의한 화합물 A의 치료학적 유효량 및 치료학적으로 불활성인 담체물질을 함유하는 약제.
  4. 제3항에 있어서, 부가활성물질로서 할로페리돌과 같은 신경이 완제를 함유하는 약제.
  5. 제1항에 있어서, 정의한 화합을 A의 치료학적 유효량을 치료학적으로 불활성인 담체 물질과 함께 이의 치료를 필요로 하는 환자에게 투여함을 특징으로 하여, 정신 질환 특히 정신분열증의 치료 및 이의 악화를 방지하는 방법.
  6. 제1항에서 정의한 화합물 A의 치료학적 유효량 및 할로페리돌과 같은 신경이 완제를 치료학적으로 불환성인 담체 물질과 함께 이의 치료를 필요로하는 환자에게 투여함을 특징으로 하며, 정신질환 특히 정신분열증의 치료 및 이의 악화를 방지하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890000282A 1988-01-15 1989-01-13 정신병 치료용 이미다조벤조디아제핀 함유 약제 KR970010055B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH143/88 1988-01-15
CH00143/88-6 1988-01-15
CH14388 1988-01-15

Publications (2)

Publication Number Publication Date
KR890011598A true KR890011598A (ko) 1989-08-21
KR970010055B1 KR970010055B1 (ko) 1997-06-20

Family

ID=4180229

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890000282A KR970010055B1 (ko) 1988-01-15 1989-01-13 정신병 치료용 이미다조벤조디아제핀 함유 약제

Country Status (15)

Country Link
US (1) US4914095A (ko)
EP (1) EP0331871B1 (ko)
JP (1) JPH0780771B2 (ko)
KR (1) KR970010055B1 (ko)
AT (1) ATE97811T1 (ko)
AU (1) AU609564B2 (ko)
CA (1) CA1327008C (ko)
DE (1) DE58906269D1 (ko)
DK (1) DK14489A (ko)
ES (1) ES2060675T3 (ko)
HU (1) HU206623B (ko)
IE (1) IE63520B1 (ko)
IL (1) IL88921A0 (ko)
PH (1) PH24888A (ko)
ZA (1) ZA89159B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1312825C (en) * 1988-01-27 1993-01-19 F. Hoffmann-La Roche Ag Prevention or interruption of panic states with an imidazobenzodiazepine
IE910939A1 (en) * 1990-04-13 1991-10-23 Neurosearch As Use of benzodiazepine compounds
US5312819A (en) * 1990-08-20 1994-05-17 Sandoz Ltd. Pharmaceutical compositions comprising clozapine and a radical scavenger
CA2055308A1 (en) * 1990-11-29 1992-05-30 Roman Amrein Imidazobenzodiazepine for the treatment of sleep disorders
TW587938B (en) * 1997-03-27 2004-05-21 Akzo Nobel Nv Pharmaceutical composition for the treatment and/or prophylaxis of psychotic disorder
RU2696683C1 (ru) * 2018-02-27 2019-08-05 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СтГМУ Минздрава России) Способ купирования резистентного обсессивно-фобического синдрома эндогенного генеза и резистентного сенесто-ипохондрического синдрома эндогенного генеза.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA806016B (en) * 1979-10-04 1981-09-30 Hoffmann La Roche Imidazodiazepine derivatives
CA1184175A (en) * 1981-02-27 1985-03-19 Walter Hunkeler Imidazodiazepines
CA1185602A (en) * 1981-02-27 1985-04-16 Emilio Kyburz Imidazodiazepines
US4352817A (en) * 1981-02-27 1982-10-05 Hoffmann-La Roche Inc. Imidazo-diazepines and their use
DE3432974A1 (de) * 1983-09-12 1985-04-04 The Upjohn Co., Kalamazoo, Mich. Arzneimittel zur prophylaxe oder therapie der negativen shizophreniesymtome bei menschen
CA1312825C (en) * 1988-01-27 1993-01-19 F. Hoffmann-La Roche Ag Prevention or interruption of panic states with an imidazobenzodiazepine

Also Published As

Publication number Publication date
PH24888A (en) 1990-12-26
HUT50635A (en) 1990-03-28
ZA89159B (en) 1990-06-27
DE58906269D1 (de) 1994-01-13
AU2841489A (en) 1989-07-20
IE890086L (en) 1989-07-15
HU206623B (en) 1992-12-28
EP0331871B1 (de) 1993-12-01
EP0331871A3 (en) 1990-09-05
JPH01216933A (ja) 1989-08-30
CA1327008C (en) 1994-02-15
ATE97811T1 (de) 1993-12-15
DK14489A (da) 1989-07-16
IE63520B1 (en) 1995-05-03
IL88921A0 (en) 1989-08-15
EP0331871A2 (de) 1989-09-13
US4914095A (en) 1990-04-03
KR970010055B1 (ko) 1997-06-20
ES2060675T3 (es) 1994-12-01
DK14489D0 (da) 1989-01-13
AU609564B2 (en) 1991-05-02
JPH0780771B2 (ja) 1995-08-30

Similar Documents

Publication Publication Date Title
ATE364699T1 (de) Humanisierte antikörper gegen humanes gp39, zusammensetzungen die diese enthalten und deren therapeutische verwendungen
DE69521994D1 (de) Zusammensetzungen welche dna zerstoerende agentien und p53 enthalten
GEP20033081B (en) Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas
KR890011598A (ko) 정신병 치료용 이미다조 벤조디아제핀
KR900001693A (ko) 아자사이클릭 화합물, 이의 제조방법 및 이의 용도
ATE49970T1 (de) Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE2333T1 (de) 4,6-di-0-(aminoglycosyl)-1,3-diaminocyclitolderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel.
ATE18050T1 (de) Triazolochinazoline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE104553T1 (de) Cytostatische und cytotoxische wirkstoffkombination zur anwendung in therapeutischen verfahren.
ATE66230T1 (de) Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
DE68901172D1 (de) (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
FR2407717A1 (fr) Usage therapeutique nouveau de l'acetyl-1-carnitine
ATE1013T1 (de) Hexahydro-1,4-oxazepine, verfahren zu deren herstellung und diese enthaltende arzneimittel.
ATE5480T1 (de) Thiazolo(3,2-a)pyrimidinderivate, ihre herstellung und arzneimittel, die diese derivate enthalten.
RU95116448A (ru) Производные пирролидина, способ их получения и содержащие их лекарственные средства
KR920703593A (ko) 이미다조퀴녹살린 화합물, 이의 제조방법 및 용도
KR920009403A (ko) 수면장해 치료용 이미다조벤조디아제핀
KR920703594A (ko) 이미다조퀴녹살린 화합물, 이의 제조방법 및 용도
FR2699920B1 (fr) Dérivés d'imidazo [2,1-b] benzothiazole-3-acétamide, leur préparation et leur application en thérapeutique.
RU95107706A (ru) Пиридоиндолобензодиазепины и их производные, фармацевтическая композиция антипсихоточеского действия на их основе и способ лечения
GR3003525T3 (ko)
EP0276805A3 (en) Substituted 3-phenyl-7h-thiazoloû3,2-b¨û1,2,4¨triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds
IT1272740B (it) Composizioni farmaceutiche contenenti una sostanza attiva fosfatidilinositolo atte alla terapia delle neurpatie periferiche da diabete mellito
FR2700547B1 (fr) Dérivés d'imidazo[2,1-b]benzosélénazole-3-acétamide, leur préparation et leur application en thérapeutique.

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20000614

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee